Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a new investigational drug, pirfenidone,
will be an effective therapy for diabetic patients with kidney dysfunction. Our hypothesis is
that administration of pirfenidone to type 1 and type 2 diabetic patients with advanced
kidney disease will lead to preservation of kidney function.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sharma, Kumar, M.D.
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH)